Found 8 matching trials
Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination
PHASE3The purpose of this phase 3 multicenter, randomized, double-blind, placebo-...
Status
Active Not Recruiting
Location
Alliance for Multispecialty Research, LLC
Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years
PHASE3The purpose of this phase 3, randomized, double-blind, placebo-controlled s...
Location
Suncoast Research Associates, LLC
A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine
PHASE2The objective of this study is to assess the safety and immunogenicity of P...
Location
Johnson County ClinTrials
An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults
PHASE3Study EBSI-CV-317-007 is a field study to evaluate the efficacy, immunogeni...
Location
WRAIR-AFRIMS Philippines, Cebu (WRAIR-APC)
Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults
PHASE2This is a multicenter, randomized, placebo-controlled, double-blind study t...
Location
Instituto Dermatológico y Cirugía de Piel
Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults
PHASE2The goal of this Phase 2 trial is to evaluate the immune response to and sa...
Location
Johnson County Clin-Trials
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)
PHASE3The goal of this multi-center, randomized, double blind, placebo controlled...
Location
Optimal Research, LLC
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
PHASE3The goal of this multi-center, randomized, double-blind, placebo-controlled...
Location
ARK Clinical Research, LLC